touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/targeting-pathobio-of-ESCC-and-emerging-impact-of-IO
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer
The practicalities of eosinophilic oesophagitis management: A closer look at emerging biologic treatment options
The practicalities of eosinophilic oesophagitis management: A closer look at emerging biologic treatment options
Treatment sequencing and the benefits of DMTs
Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer
How can real-world evidence guide the management of elderly and frail patients with multiple myeloma?
Navigating the challenges of treatment provision in recurrent/metastatic HNSCC
Managing EoE: What options are emerging for patients? - Conversation 3
Symptoms of EoE: What is the burden for patients? - Conversation 2
Pathophysiology of EoE: What do we see in patients? - Conversation 1
Managing EoE: What options are emerging for patients? - Conversation 3
Symptoms of EoE: What is the burden for patients? Conversation 2
Pathophysiology of EoE What do we see in patients - Conversation 1
Experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis
Experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis
MDT and patient advocate perspectives on what can be learned from patients with CML
MDT perspectives on maximizing quality of life for patients with CML
MDT perspectives on minimizing TKI-associated toxicities in patients with CML
MDT perspectives on later-line treatment options for CML
Extending the benefit of PARP inhibitors through combinations for advanced prostate cancer - Conversation 3
Create your
podcast in
minutes
It is Free
The Psychic Elephant Radio Podcast
DNA Today: A Genetics Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain